Navigation Links
Oncothyreon highlights corporate and clinical objectives for 2008
Date:1/28/2008

BELLEVUE, WA, Jan. 28 /PRNewswire-FirstCall/ - Oncothyreon Inc. (the "Company") (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today provided a review of the Company's clinical development plans and corporate objectives for 2008. Oncothyreon is developing both novel synthetic vaccines and targeted small molecules with the potential to improve the lives and outcomes of cancer patients.

"During 2008, our primary focus will continue to be the advancement of our clinical pipeline," said Robert L. Kirkman, M.D., President and Chief Executive Officer of Oncothyreon. "We are committed to the rapid development of our product candidates as the best strategy for building long-term value for our shareholders and achieving our vision of developing important new cancer therapies."

"As we advance our clinical programs, we also remain committed to prudent management of our financial resources," continued Dr. Kirkman. "The manufacturing revenue and milestone payments we anticipate receiving under our collaboration with Merck KGaA of Darmstadt, Germany for Stimuvax(R) are expected to support the further development of this product without material additional investment by Oncothyreon. We believe Stimuvax has substantial upside potential if it is approved and marketed, as our agreements with Merck KGaA include significant commercialization milestones and royalties on Stimuvax sales. With respect to our small molecule programs, we are actively seeking a partner for one or more of our product candidates, in order to provide additional resources for these product candidates, while generating revenue to support ongoing development of other compounds
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Biomira announces plan to change name to Oncothyreon
2. Highlights of Economic and Business Growth in the Tampa Bay Region
3. Highlights of Economic and Business Growth in the Tampa Bay Region
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
6. Highlights of Economic and Business Growth in the Tampa Bay Region
7. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
8. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
9. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
10. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
11. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Davis, California (PRWEB) January 22, 2015 ... of Accelerator Mass Spectrometry (AMS) services to the pharmaceutical ... PhD has joined the company in the position of ... 30 years of broad and valuable experience in drug ...
(Date:1/22/2015)... January 21, 2015 Cambridge Semantics, the leading ... today announced that 2014 was a record-breaking year across the ... of the Anzo Smart Data Platform and our Smart Data ... insights from diverse data which led to record growth for ...
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
Breaking Biology Technology:Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 2Eckert & Ziegler Vitalea Science appoints Mark Seymour, PhD as Director of Science & Technology 3Cambridge Semantics Announces Record Results for 2014 23D Motion Capture Just Got Easy 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... - United Arab Emirates   is the First ... to Region,s Allergy Sufferers - Nycomed, a ... now available in the United Arab Emirates for the treatment ... fever, in adults and adolescents over the age of 12. ...
... 13, 2012   Health Care Compliance Strategies, Inc. ... System of Wichita, Kansas has realized a 90% ... months after selecting and implementing COI-SMART, the system ... (Logo: http://photos.prnewswire.com/prnh/20061010/NYTU194LOGO ) ...
... DALLAS, March 13, 2012   Kimberly-Clark Corporation (NYSE: ... "Bob" Stargel Jr., vice president of Global Nonwovens, has ... "Most Influential Blacks in Corporate America." The Top ... international business leaders and executives representing a diverse range ...
Cached Biology Technology:Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis 2Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis 3Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis 4Conflict of Interest Management System Selected by Via Christi Health 2Conflict of Interest Management System Selected by Via Christi Health 3Kimberly-Clark's Bob Stargel Named One of Savoy Magazine's Top 100 Most Influential Blacks in Corporate America 2Kimberly-Clark's Bob Stargel Named One of Savoy Magazine's Top 100 Most Influential Blacks in Corporate America 3
(Date:1/22/2015)... TORONTO , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the ... announced the launch of its new website design. ... in its infancy", says Peter O,Neill , founder and ... ever, the industry needs involvement from the key players on ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... , Europe,s most prestigious innovation ... to present a video retrospective of the most exciting and innovative ... Toumazou and Sophie Wilson   A different ...   Starting on 22 January 2015 on   http://www.epo.org/european-inventor   ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
... in Cte d,Ivoire, researchers estimate that this endangered subspecies has ... last survey was conducted 18 years ago. The few remaining ... living in Ta National Park, according to a report in ... Cell Press publication. This alarming decline in a country ...
... When it comes to embryo formation in the ... to enhanced developmental precision, according to a study in ... Cincinnati Children,s Hospital Medical Center. While the fundamentals ... one day they could matter quite a bit to ...
... different parts of the brain can come under attack in ... in mice with an MS-like disease, the brain,s response to ... the spinal cord or cerebellum that comes under fire. The ... in Baltimore and Washington University in St. Louiswill be published ...
Cached Biology News:In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline 2Scientists trace molecular origin of proportional development 2Scientists trace molecular origin of proportional development 3
Mouse monoclonal antibody to FMN2 - formin 2...
...
Anti-Human Complement Component C4c, IgY fraction (Polyclonal) (chicken IgY)...
... (KLF15) KLF15 is a Cys2-His2 zinc ... in the liver, kidneys, heart, and skeletal ... Polyclonal antibody produced in rabbits immunized with ... of human KLF15 with an internal ID ...
Biology Products: